The Diagnostic and clinical significance of anti-muscarinic receptor autoantibodies

Clinical Reviews in Allergy and Immunology

Volumn 42, Issue 3, 2012, Pages 298-308

  Nussinovitch, Udi ^a,b   Shoenfeld, Yehuda ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Anti M2 muscarinic receptor autoantibodies; Autoantibodies; Autoimmunity; Chagas heart disease; Dilated cardiomyopathy

Indexed keywords

AUTOANTIBODY; CARBACHOL; MUSCARINIC M2 RECEPTOR; MUSCARINIC RECEPTOR AUTOANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ATHEROSCLEROSIS; BRADYCARDIA; CHAGAS DISEASE; CONGESTIVE CARDIOMYOPATHY; CROSS REACTION; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART MUSCLE CELL; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; MOLECULAR MIMICRY; MYOCARDITIS; NONHUMAN; REPOLARIZATION; REVIEW; RHEUMATIC FEVER;

ANIMALS; ARRHYTHMIAS, CARDIAC; AUTOANTIBODIES; AUTOIMMUNITY; CARDIOMYOPATHY, DILATED; CHAGAS CARDIOMYOPATHY; HUMANS; IMMUNOTHERAPY; MYOCYTES, CARDIAC; RECEPTOR, MUSCARINIC M2; SEROEPIDEMIOLOGIC STUDIES;

EID: 84865262739     PISSN: 10800549     EISSN: 15590267     Source Type: Journal    
DOI: 10.1007/s12016-010-8235-x     Document Type: Review

References (72)

1. Nussinovitch U, Shoenfeld Y (2010) Anti-troponin autoantibodies and the cardiovascular system. Heart 96:1518-1524
2. Nussinovitch U, Shoenfeld Y (2009) Autoimmunity and heart diseases: Pathogenesis and diagnostic criteria. Arch Immunol Ther Exp (Warsz) 57:95-104
3. Nussinovitch U, Shoenfeld Y (2008) Intravenous immunoglobulin -indications and mechanisms in cardiovascular diseases. Autoimmun Rev 7:445-452
4. Nussinovitch U, Shoenfeld Y (2008) Autoimmune dilated cardiomyopathy. In: Shoenfeld Y, Cervera R, Gershwin M (eds) Diagnostic criteria in autoimmune diseases. The Humana Press Inc, New Jersey, pp 367-372
5. Nussinovitch U, Shoenfeld Y (2010) Atherosclerosis and macro-vascular involvement in systemic sclerosis: Myth or reality. Autoimmun Rev doi:10.1111/j.1365-2249.2010.04265.x
6. Nussinovitch U, Shoenfeld Y (2009) Autoimmune mechanisms in cardiovascular diseases. Harefuah 148
7. Jahns R, Boivin V, Lohse MJ (2006) Beta 1-adrenergic receptor-directed autoimmunity as a cause of dilated cardiomyopathy in rats. Int J Cardiol 112:7-14
8. Brucato A, Maestroni S, Cumetti D et al (2008) Recurrent pericarditis: Infectious or autoimmune?. Autoimmun Rev 8:44-47
9. Gershwin ME (2008) The mosaic of autoimmunity. Autoimmun Rev 7:161-163
10. Stojanovich L, Marisavljevich D (2008) Stress as a trigger of autoimmune disease. Autoimmun Rev 7:209-213
11. Retondaro FC, Dos Santos Costa PC, Pedrosa RC, Kurtenbach E (1999) Presence of antibodies against the third intracellular loop of the M2 muscarinic receptor in the sera of chronic chagasic patients. FASEB J 13:2015-2020
12. Gleicher N, Barad D, Weghofer A (2007) Functional autoantibodies, a new paradigm in autoimmunity?. Autoimmun Rev 7:42-45
13. Fritzler MJ (2008) Challenges to the use of autoantibodies as predictors of disease onset, diagnosis and outcomes. Autoimmun Rev 7:616-620
14. Shoenfeld Y, Blank M, Abu-Shakra M et al (2008) The mosaic of autoimmunity: Prediction, autoantibodies, and therapy in autoimmune diseases-2008. Isr Med Assoc J 10:13-19
15. Jahns R, Boivin V, Schwarzbach V, Ertl G, Lohse MJ (2008) Pathological autoantibodies in cardiomyopathy. Autoimmunity 41:454-461
16. Deubner N, Berliner D, Schlipp A et al (2010) Cardiac beta1-adrenoceptor autoantibodies in human heart disease: Rationale and design of the Etiology, Titre-Course, and Survival (ETiCS) Study. Eur J Heart Fail 12:753-762
17. Kaya Z, Katus HA, Rose NR (2009) Cardiac troponins and autoimmunity: Their role in the pathogenesis of myocarditis and of heart failure. Clin Immunol
18. Shmilovich H, Danon A, Binah O et al (2007) Autoantibodies to cardiac troponin I in patients with idiopathic dilated and ischemic cardiomyopathy. Int J Cardiol 117:198-203
19. Lazzerini PE, Capecchi PL, Guideri F et al (2008) Autoantibody-mediated cardiac arrhythmias: Mechanisms and clinical implications. Basic Res Cardiol 103:1-11
20. Peter JC, Tugler J, Eftekhari P, Maurice D, Hoebeke J, Roegel JC (2005) Effects on heart rate of an anti-M2 acetylcholine receptor immune response in mice. FASEB J 19:943-949
21. Fu M, Schulze W, Wolf WP, Hjalmarson A, Hoebeke J (1994) Immunocytochemical localization of M2 muscarinic receptors in rat ventricles with anti-peptide antibodies. J Histochem Cytochem 42:337-343
22. Fu ML (1996) Anti-M2 muscarinic receptor autoantibodies and idiopathic dilated cardiomyopathy. Int J Cardiol 54:127-135
23. Fleming JW, Strawbridge RA, Watanabe AM (1987) Muscarinic receptor regulation of cardiac adenylate cyclase activity. J Mol Cell Cardiol 19:47-61
24. Watanabe AM, Lindemann JP, Fleming JW (1984) Mechanisms of muscarinic modulation of protein phosphorylation in intact ventricles. Fed Proc 43:2618-2623
25. Paaerez Leiros C, Sterin-Borda L, Cossio P, Borda ES (1990) Muscarinic cholinergic antibody in experimental autoimmune myocarditis regulates cardiac function. Proc Soc Exp Biol Med 195:356-363
26. Sterin-Borda L, Gorelik G, Borda ES (1991) Chagasic IgG binding with cardiac muscarinic cholinergic receptors modifies cholinergic-mediated cellular transmembrane signals. Clin Immunol Immunopathol 61:387-397
27. Gorelik G, Genaro AM, Sterin-Borda L, Gonzalez Cappa S, Borda ES (1990) Antibodies bind and activate beta adrenergic and cholinergic lymphocyte receptors in Chagas' disease. Clin Immunol Immunopathol 55:221-236
28. Fu LX, Magnusson Y, Bergh CH et al (1993) Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy. J Clin Invest 91:1964-1968
29. Gimenez LE, Hernandez CC, Mattos EC et al (2005) DNA immunizations with M2 muscarinic and beta1 adrenergic receptor coding plasmids impair cardiac function in mice. J Mol Cell Cardiol 38:703-714
30. Leiros CP, Sterin-Borda L, Borda ES, Goin JC, Hosey MM (1997) Desensitization and sequestration of human m2 muscarinic acetylcholine receptors by autoantibodies from patients with Chagas' disease. J Biol Chem 272:12989-12993
31. Fu ML, Hoebeke J, Matsui S et al (1994) Autoantibodies against cardiac G-protein-coupled receptors define different populations with cardiomyopathies but not with hypertension. Clin Immunol Immunopathol 72:15-20
32. Fu M (2009) Autoantibodies in atrial fibrillation: Actors, biomarkers or bystanders? How far have we come?. Cardiology 112:178-179
33. Baba A, Yoshikawa T, Fukuda Y et al (2004) Autoantibodies against M2-muscarinic acetylcholine receptors: New upstream targets in atrial fibrillation in patients with dilated cardiomyopathy. Eur Heart J 25:1108-1115
34. Caforio AL, Daliento L, Angelini A et al (2005) Autoimmune myocarditis and dilated cardiomyopathy: Focus on cardiac autoantibodies. Lupus 14:652-655
35. Liu HR, Zhao RR, Zhi JM, Wu BW, Fu ML (1999) Screening of serum autoantibodies to cardiac beta1-adrenoceptors and M2-muscarinic acetylcholine receptors in 408 healthy subjects of varying ages. Autoimmunity 29:43-51
36. Hong CM, Zheng QS, Liu XT, Shang FJ, Wang HT, Jiang WR (2009) Effects of autoantibodies against M2 muscarinic acetylcholine receptors on rabbit atria in vivo. Cardiology 112:180-187
37. Perez Leiros C, Goren N, Sterin-Borda L, Lustig L, Borda E (1994) Alterations in cardiac muscarinic acetylcholine receptors in mice with autoimmune myocarditis and association with circulating muscarinic receptor-related autoantibodies. Clin Auton Res 4:249-255
38. Wallukat G, Fu HM, Matsui S, Hjalmarson A, Fu ML (1999) Autoantibodies against M2 muscarinic receptors in patients with cardiomyopathy display non-desensitized agonist-like effects. Life Sci 64:465-469
39. Wang WZ, Zhao RR, Wu BW et al (1996) Effects of anti-peptide antibodies against human M2 muscarinic receptors on cardiac function in rats in vivo. Blood Press Suppl 3:25-27
40. Goin JC, Leiros CP, Borda E, Sterin-Borda L (1997) Interaction of human chagasic IgG with the second extracellular loop of the human heart muscarinic acetylcholine receptor: Functional and pathological implications. FASEB J 11:77-83
41. Wallukat G, Nissen E, Morwinski R, Muller J (2000) Autoantibodies against the beta- and muscarinic receptors in cardiomyopathy. Herz 25:261-266
42. Dobrev D, Christ T, Ravens U (2004) Muscarinic subtype-2 receptor autoantibodies: Actors or bystanders in human atrial fibrillation?. Eur Heart J 25:1091-1092
43. Nascimento JH, Salle L, Hoebeke J, Argibay J, Peineau N (2001) cGMP-mediated inhibition of cardiac L-type Ca(2+) current by a monoclonal antibody against the M(2) ACh receptor. Am J Physiol Cell Physiol 281:C1251-C1258
44. Wang W, Guo G, Tang J et al (2000) Stimulatory activity of antipeptide antibodies against the second extracellular loop of human M2 muscarinic receptors. Chin Med J (Engl) 113:867-871
45. Ganzinelli S, Borda E, Joensen L, Sterin-Borda L (2009) Chagasic antibodies induce cardiac COX-2/iNOS mRNA expression with PGE2/NO production. Int J Cardiol 134:212-223
46. Lappe JM, Pelfrey CM, Tang WH (2008) Recent insights into the role of autoimmunity in idiopathic dilated cardiomyopathy. J Card Fail 14:521-530
47. Miettinen KH, Eriksson S, Magga J et al (2008) Clinical significance of troponin I efflux and troponin autoantibodies in patients with dilated cardiomyopathy. J Card Fail 14:481-488
48. Nussinovitch U, de Carvalho JF, Pereira RM, Shoenfeld Y (2010) Glucocorticoids and the cardiovascular system: State of the art. Curr Pharm Des
49. Matsui S, Fu M, Hayase M et al (2006) Transfer of immune components from rabbit autoimmune cardiomyopathy into severe combined immunodeficiency (SCID) mice induces cardiomyo-pathic changes. Autoimmunity 39:121-128
50. Yoshikawa T, Baba A, Nagatomo Y (2009) Autoimmune mechanisms underlying dilated cardiomyopathy. Circ J 73:602-607
51. Nagatomo Y, Yoshikawa T, Kohno T et al (2009) A pilot study on the role of autoantibody targeting the beta1-adrenergic receptor in the response to beta-blocker therapy for congestive heart failure. J Card Fail 15:224-232
52. Jahns R, Boivin V, Krapf T, Wallukat G, Boege F, Lohse MJ (2000) Modulation of beta1-adrenoceptor activity by domain-specific antibodies and heart failure-associated autoantibodies. J Am Coll Cardiol 36:1280-1287
53. Staudt Y, Mobini R, Fu M, Felix SB, Kuhn JP, Staudt A (2003) Beta1-adrenoceptor antibodies induce apoptosis in adult isolated cardiomyocytes. Eur J Pharmacol 466:1-6
54. Wallukat G, Muller J, Hetzer R (2002) Specific removal of beta1-adrenergic autoantibodies from patients with idiopathic dilated cardiomyopathy. N Engl J Med 347:1806
55. Chiale PA, Ferrari I, Mahler E et al (2001) Differential profile and biochemical effects of antiautonomic membrane receptor antibodies in ventricular arrhythmias and sinus node dysfunction. Circulation 103:1765-1771
56. Matsui S, Fu ML, Katsuda S et al (1997) Peptides derived from cardiovascular G-protein-coupled receptors induce morphological cardiomyopathic changes in immunized rabbits. J Mol Cell Cardiol 29:641-655
57. Matsui S, Fu ML, Hayase M et al (1999) Active immunization of combined beta1-adrenoceptor and M2-muscarinic receptor peptides induces cardiac hypertrophy in rabbits. J Card Fail 5:246-254
58. Mahler E, Hoebeke J, Levin MJ (2004) Structural and functional complexity of the humoral response against the Trypanosoma cruzi ribosomal P2 beta protein in patients with chronic Chagas' heart disease. Clin Exp Immunol 136:527-534
59. Ribeiro AL, Gimenez LE, Hernandez CC et al (2007) Early occurrence of anti-muscarinic autoantibodies and abnormal vagal modulation in Chagas disease. Int J Cardiol 117:59-63
60. Talvani A, Rocha MO, Ribeiro AL, Borda E, Sterin-Borda L, Teixeira MM (2006) Levels of anti-M2 and anti-beta1 autoantibodies do not correlate with the degree of heart dysfunction in Chagas' heart disease. Microbes Infect 8:2459-2464
61. Ribeiro AL, de Carvalho AC, Lombardi F, Teixeira MM, Rocha MO (2009) Enhanced parasympathetic activity in Chagas disease still stands in need of proof. Int J Cardiol 135:406-408
62. de Oliveira SF, Pedrosa RC, Nascimento JH, Campos de Carvalho AC, Masuda MO (1997) Sera from chronic chagasic patients with complex cardiac arrhythmias depress electrogenesis and conduction in isolated rabbit hearts. Circulation 96:2031-2037
63. Ferrari I, Levin MJ, Elizari MV, Rosenbaum MB, Chiale PA (1997) Cholinergic autoantibodies in sinus-node dysfunction. Lancet 350:262-263
64. Chiale PA, Garro HA, Schmidberg J et al (2006) Inappropriate sinus tachycardia may be related to an immunologic disorder involving cardiac beta andrenergic receptors. Heart Rhythm 3:1182-1186
65. Medei E, Pedrosa RC, Benchimol Barbosa PR et al (2007) Human antibodies with muscarinic activity modulate ventricular repolarization: Basis for electrical disturbance. Int J Cardiol 115:373-380
66. Nussinovitch N, Livneh A, Katz K et al (2010) QT dispersion in uncomplicated familial Mediterranean fever. Clin Rheumatol 29:1353-1356
67. Nussinovitch U, Katz U, Nussinovitch M, Nussinovitch N (2009) Late ventricular potentials and QT dispersion in familial dysautonomia. Pediatr Cardiol 30:747-751
68. Muller J, Wallukat G, Dandel M et al (2000) Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Circulation 101:385-391
69. Baba A, Akaishi M, Shimada M et al (2010) Complete elimination of cardiodepressant IgG3 autoantibodies by immunoadsorption in patients with severe heart failure. Circ J 74:1372-1378
70. Kivity S, Katz U, Daniel N, Nussinovitch U, Papageorgiou N, Shoenfeld Y (2009) Evidence for the use of intravenous immunoglobulins - A review of the literature. Clin Rev Allergy Immunol
71. Stavrakis S, Yu X, Patterson E et al (2009) Activating autoantibodies to the beta-1 adrenergic and m2 muscarinic receptors facilitate atrial fibrillation in patients with Graves' hyperthyroidism. J Am Coll Cardiol 54:1309-1316
72. Elies R, Ferrari I, Wallukat G et al (1996) Structural and functional analysis of the B cell epitopes recognized by antireceptor autoantibodies in patients with Chagas' disease. J Immunol 157:4203-4211